Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital

Last updated: February 14, 2025
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Muscle Pain

Chronic Pain

Acute Pain

Treatment

N/A

Clinical Study ID

NCT06832046
9480
  • Ages 1-17
  • All Genders

Study Summary

Emergency trauma departments receive thousands of patients each year whose main symptom is pain. In recent years, intranasal fentanyl (FIN) has entered the therapeutic arsenal to treat pain in the emergency department. Various studies have validated its effectiveness for musculoskeletal pain as well as its tolerance and safety of use. Since then, new protocols have been implemented including this treatment. In This study, the investigators propose to retrospectively study the quality of prescription of intranasal fentanyl in the treatment of pain in the emergency department and the quality of monitoring of this treatment in current practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Child < 18 years old

  • Child treated in the pediatric emergency department of Strasbourg UniversityHospital

  • Child who has benefited from intranasal fentanyl between 08/01/2022 and 09/31/2024.

  • Child (and/or his/her parental authority) who has not expressed, after information,his/her (their) opposition to the reuse of his/her health data for the purposes ofthis research.

Exclusion

Exclusion Criteria:

  • Refusal of the child (and/or his/her parent) to participate in the study

  • Patient's medical file not incomplete

  • Child not domiciled in France.

Study Design

Total Participants: 500
Study Start date:
October 28, 2024
Estimated Completion Date:
April 28, 2026

Connect with a study center

  • Service d'Urgences Médico-Chirurgicales Pédiatriques - CHU de Strasbourg - France

    Strasbourg, 67091
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.